Definitive Contract 75A50122C00010
Award Date
1/24/22
Potential Completion Date
10/26/26
Potential Value
$35M
Awardee
Detect Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Guilford, CT 06437, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...
This is a $17,325,268.78 cost-plus-fixed-fee contract awarded to Biofire Defense LLC on September 29, 2023 by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract objective is to advance the development of Biofire's Emerging Flu Panel as a nucleic acid detection assay for use on the Biofire FilmArray Torch and Spotfire platforms. This work is related to a previous Broad Agency Announcement from the Biomedical Advanced Research and Development Authority (BARDA)...
This is a $725,368.36 Firm Fixed Price (FFP) contract awarded to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract is for a research and development effort to develop a rapid detection test for severe, dysregulated host immune response to infection in pediatrics. The contract has a base period of performance through September 30, 2025 and was awarded on June 30, 2022. This contract was issued...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Battelle Memorial Institute, a nonprofit research and development organization, for the development of an assay for influenza virus. The $229,734,110.01 contract has a cost-plus-fixed-fee pricing type and an ultimate completion date of January 17, 2022. Battelle has subcontracted a portion of the work to Diagnostic Consulting Network, LLC (DCN Diagnostics), a for-profit limited liability company,...
This is a $24,860,014.00 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Mesa Biotech Inc. for the development of an easy-to-use, low-cost molecular-based SARS-CoV-2 test. The contract is part of the Rapid Acceleration of Diagnostics (RADx) program, which aims to accelerate the development, validation, and commercialization of innovative COVID-19 testing technologies. The contract has a performance period ending on May 4, 2024,...
This is a $748,027.21 firm fixed price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Senzo, Inc. for the development of a high-sensitivity, home-based, over-the-counter COVID-19 rapid diagnostic test. The contract was awarded under AOI #11A of ASPR's Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA), which focuses on home-based diagnostics for SARS-CoV-2 detection. The contract has a period of...
This is a $2,400,000.00 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Watmind USA, Inc., a small disadvantaged business. The contract is to provide 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The objective is to ensure the government is...
This is a $9,374,751 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Sherlock Biosciences, Inc., a for-profit company specializing in rapid, field-deployable molecular diagnostics based on CRISPR technology. The contract is for the development of a low-cost, point-of-need molecular test for influenza A and B that can utilize self-collected swab specimens. This contract...
This is a $14,448.00 fixed-price delivery order awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency Troop Support Medical. The contract is for the provision of the "EUA XPERT XPRESS SARS-COV-2/FLU/RSV+" diagnostic test, which can detect multiple respiratory viruses including SARS-CoV-2, influenza, and respiratory syncytial virus. The contract has a completion date of February 7, 2024 and does not have a set-aside designation....